Back to compounds

COMPOUND PROFILE / PROTEINS & BIOLOGICS

Insulin Glargine.

Research draft

Insulin glargine is a long-acting basal insulin analogue.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

Insulin glargine is a long-acting basal insulin analogue.

CLASSIFICATIONProteins & biologics
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCompound

Mechanism

Its formulation supports prolonged absorption after subcutaneous administration.

Human research

Extensive clinical use and randomised comparison studies support diabetes treatment.

Preclinical & other research

Pharmacology studies characterise absorption and duration.

Safety & unknowns

Severe hypoglycaemia is a central risk. Different concentrations and products are not automatically interchangeable.

Regulatory status

Approved products exist with formulation-specific labels.

Reported use & evidence

Research profile draft

The supplied Insulin Glargine profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds